[Massive inferior vena cava thrombosis associated with protein C deficiency. Clinical case].
Inferior vena cava thrombosis is infrequent and in 30% of cases, the potential cause is an alteration of the natural anticoagulant protein system. We report a 18 years old male with an inferior vena cava thrombosis that was associated to a protein C deficiency. He was successfully treated with an infusion of intravenous streptokinase during 30 hours and intravenous heparin during 10 days, followed by oral anticoagulation therapy.
Duclos
J
J
Facultad de Medicina, Universidad de Valparaíso, Hospital Naval Almirante Nef, Viña del Mar.
Castro
J
J
Cofré
P
P
Saiz
X
X
D000293:Adolescent; D000925:Anticoagulants / Q000627:therapeutic use; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D020151:Protein C Deficiency; D013300:Streptokinase / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D014682:Vena Cava, Inferior
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin; D013300:Streptokinase
Trombosis masiva de vena cava inferior asociada a déficit de proteína C. Caso clínico.